Cargando…

Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model

Vascular endothelial growth factor (VEGF) is an angiogenic factor critically involved in tumor progression. Adenosine A2B receptor plays a pivotal role in promoting tumor growth. The aim of this study was to investigate the role of myeloid-derived suppressor cells (MDSCs) in the pro-angiogenic effec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sorrentino, Claudia, Miele, Lucio, Porta, Amalia, Pinto, Aldo, Morello, Silvana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4695003/ https://www.ncbi.nlm.nih.gov/pubmed/26317647

Ejemplares similares

Activation of the A2B adenosine receptor in B16 melanomas induces CXCL12 expression in FAP-positive tumor stromal cells, enhancing tumor progression
por: Sorrentino, Claudia, et al.
Publicado: (2016)

Targeting the adenosine A2b receptor in the tumor microenvironment overcomes local immunosuppression by myeloid-derived suppressor cells
por: Morello, Silvana, et al.
Publicado: (2014)

Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells
por: Sorrentino, Claudia, et al.
Publicado: (2019)

Corrigendum: Adenosine A2A Receptor Stimulation Inhibits TCR-Induced Notch1 Activation in CD8+T-Cells
por: Sorrentino, Claudia, et al.
Publicado: (2019)

Plasmacytoid Dendritic Cells: From Heart to Vessels
por: Sorrentino, Rosalinda, et al.
Publicado: (2010)

The adenosinergic system in cancer: Key therapeutic target
por: Sorrentino, Rosalinda, et al.
Publicado: (2013)

Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression
por: Groth, Christopher, et al.
Publicado: (2021)

Soluble CD73 as biomarker in patients with metastatic melanoma patients treated with nivolumab
por: Morello, Silvana, et al.
Publicado: (2017)

Adoptive Immunotherapy with Cl-IB-MECA-Treated CD8+ T Cells Reduces Melanoma Growth in Mice
por: Montinaro, Antonella, et al.
Publicado: (2012)

Multiple Roles for VEGF in Non-Melanoma Skin Cancer: Angiogenesis and Beyond
por: Johnson, Kelly E., et al.
Publicado: (2012)

Targeting SRPK1 to control VEGF-mediated tumour angiogenesis in metastatic melanoma
por: Gammons, M V, et al.
Publicado: (2014)

Granulocytic myeloid-derived suppressor cells promote angiogenesis in the context of multiple myeloma
por: Binsfeld, Marilène, et al.
Publicado: (2016)

VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma
por: Beckermann, B M, et al.
Publicado: (2008)

Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)

Dendritic cells inhibit myeloid-derived suppressor cells infiltration and function in mouse B16 melanoma microenvironment
por: Xia, Siyuan, et al.
Publicado: (2013)

Osteocyte Vegf-a contributes to myeloma-associated angiogenesis and is regulated by Fgf23
por: Mulcrone, Patrick L., et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
por: Consonni, Francesca Maria, et al.
Publicado: (2019)

Adenosine infusion increases plasma levels of VEGF in humans
por: Adair, Thomas H, et al.
Publicado: (2005)

Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma
por: Chevolet, Ines, et al.
Publicado: (2015)

Effect of Angelica polysaccharide on mouse myeloid-derived suppressor cells
por: Shen, Jie, et al.
Publicado: (2022)

VEGF tips its hand in angiogenesis
por: Short, Ben
Publicado: (2015)

Role of exosome-associated adenosine in promoting angiogenesis
por: Ludwig, Nils, et al.
Publicado: (2020)

IGFBP‐4 enhances VEGF‐induced angiogenesis in a mouse model of myocardial infarction
por: Wo, Da, et al.
Publicado: (2020)

Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective
por: Bleve, Augusto, et al.
Publicado: (2022)

The constitutive level of vascular endothelial growth factor (VEGF) is more important than hypoxia-induced VEGF up-regulation in the angiogenesis of human melanoma xenografts
por: Danielsen, T, et al.
Publicado: (2000)

Effect of Immune Checkpoint Blockade on Myeloid-Derived Suppressor Cell Populations in Patients With Melanoma
por: Sun, Steven H., et al.
Publicado: (2021)

Enhancing immunotherapy response in melanoma: myeloid-derived suppressor cells as a therapeutic target
por: Ozbay Kurt, Feyza Gul, et al.
Publicado: (2023)

Isolation of human and mouse myeloid-derived suppressor cells for metabolic analysis
por: Choi, Jee Eun, et al.
Publicado: (2022)

Angiogenesis and Melanoma
por: Ribatti, Domenico, et al.
Publicado: (2010)

Anti-VEGF therapy resistance in ovarian cancer is caused by GM-CSF-induced myeloid-derived suppressor cell recruitment
por: Horikawa, Naoki, et al.
Publicado: (2020)

Regulation of Osteogenesis-Angiogenesis Coupling by HIFs and VEGF
por: Schipani, Ernestina, et al.
Publicado: (2009)

The role of VEGF receptors in angiogenesis; complex partnerships
por: Cébe-Suarez, S., et al.
Publicado: (2006)

Biomarkers of angiogenesis and their role in the development of VEGF inhibitors
por: Murukesh, N, et al.
Publicado: (2010)

VEGF stimulated the angiogenesis by promoting the mitochondrial functions
por: Guo, Dongqing, et al.
Publicado: (2017)

miR-874 functions as a tumor suppressor by inhibiting angiogenesis through STAT3/VEGF-A pathway in gastric cancer
por: Zhang, Xiaoyu, et al.
Publicado: (2015)

The role of VEGF in melanoma progression
por: Rajabi, Parvin, et al.
Publicado: (2012)

Impaired gp100-Specific CD8(+) T-Cell Responses in the Presence of Myeloid-Derived Suppressor Cells in a Spontaneous Mouse Melanoma Model
por: Mairhofer, David G, et al.
Publicado: (2015)

A Novel PHD2/VHL-mediated Regulation of YAP1 Contributes to VEGF Expression and Angiogenesis
por: Bora-Singhal, Namrata, et al.
Publicado: (2022)

Immunological consequences of selective BRAF inhibitors in malignant melanoma: Neutralization of myeloid-derived suppressor cells
por: Schilling, Bastian, et al.
Publicado: (2013)

Myeloid-Derived Suppressor Cells (MDSC) in Melanoma Patients Treated with Anti-PD-1 Immunotherapy
por: Tomela, Katarzyna, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_r1td5f74a81n5pqn02nh5hj9th